Sorafenib and bevacizumab combination targeted therapy in advanced neuroendocrine tumour: A phase II study of Spanish Neuroendocrine Tumour Group (GETNE0801)
- Castellano, D.
- Capdevila, J.
- Sastre, J.
- Alonso, V.
- Llanos, M.
- García-Carbonero, R.
- Manzano Mozo, J.L.
- Sevilla, I.
- Durán, I.
- Salazar, R.
ISSN: 0959-8049, 1879-0852
Argitalpen urtea: 2013
Alea: 49
Zenbakia: 18
Orrialdeak: 3780-3787
Mota: Artikulua